pd 158780 has been researched along with Ovarian Neoplasms in 1 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rewcastle, GW | 1 |
| Murray, DK | 1 |
| Elliott, WL | 1 |
| Fry, DW | 1 |
| Howard, CT | 1 |
| Nelson, JM | 1 |
| Roberts, BJ | 1 |
| Vincent, PW | 1 |
| Showalter, HD | 1 |
| Winters, RT | 1 |
| Denny, WA | 1 |
1 other study available for pd 158780 and Ovarian Neoplasms
| Article | Year |
|---|---|
Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of re
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Enzyme Inhibi | 1998 |